Concerto's clinical trial, ENS-002 for Atopic Dermatitis in Adults, is now recruiting.More information
About Us
Beyond microbes, we channel synergies among humans.
Diversity was always the answer. For ecology and for humanity.
Mission
We create safe, effective microbial products for our world.
First came antibiotics. Then came genetic engineering. Concerto is catalyzing a third wave of microbial technologies to capture what microbes do best: Protect the health of our bodies, our food, and our planet. Accessing these microbial ecology-inspired products requires rigorous discovery science, a strong collaborative culture, and an unyielding commitment to improvement.
Values
Grow by experimenting
Work rigorously
Listen intently
Act with compassion
Permission to Play
Concerto embraces a foundational set of additional values that we believe ought to be evident in any startup.Team
Cheri Ackerman, PhD
Cofounder & Chief Executive Officer
Jared Kehe, PhD
Cofounder & Chief Scientific Officer
Bernardo Cervantes, PhD
Cofounder & Chief Operating Officer
Keaton Armentrout
Director of Engineering
Charles Dove
Machine Learning Engineer
Emily Bean, PhD
Senior Scientist – Microbiologist
Melanie Doezema
Senior Manager – Executive Administration
Erik Hesse
Senior Software Engineer
Matthew Volpe, PhD
Scientist II – Microbiologist
Diane Marcou
Chief Financial Officer
Michele Mara
Financial Controller
Alasdair Morton
Engineer II – Automation
Rhys Duquette
Laboratory & Operations Manager
Omobukola Solebo
Associate Scientist
Annah Sclafani, PhD
Senior Data Scientist
James Sigler
Executive VP of CMC
Eliza Zalis, PhD
Senior Manager – Analytical Development
Vanessa Sanchez
Senior Research Associate – Analytical Development
Lou Vaickus, MD
Chief Medical Officer
Alexander Lyons
Scientist – Fermentation
Olivier Charlemagne
Research Associate – Fermentation
Kevin Litcofsky, PhD
Executive Director of Discovery
Zac Swider, PhD
Software Engineer II – Image Processing
Denny Chin, PhD
Scientist – Microbiologist
Dylan West
Director of Strategy & Business Development
Stewart Campbell
Board Member – Independent Director
Vera Schroeder
Board Member
Sarah Luppino
Board Member
Laura Davis
Board Member – Observer
Vinit Nijhawan
Board Member – Observer
Paul Blainey, PhD
Scientific Advisory Board Member – Technology Advisor
Peter Lio, MD
Scientific Advisory Board Member – Dermatologic Disease KOL
Tiffany Scharschmidt, MD
Scientific Advisory Board Member – Skin Microbiome & Immunology Expert
Caroline Mitchell, MD
Scientific Advisory Board Member – OB/GYN, Vulvovaginal Disease KOL
Jasmina Jankicevic, MD
Dermatology Drug and Device Development KOL
Peter Barton Hutt
Food and Drug Law Expert
Henry Rath
Business Development Advisor
Kyle Jenne
Business Development Advisor
Jonathan Zung
Business Development AdvisorInvestors
Harness microbial ecology with Concerto to develop new, transformative products.
Partner With UsMicrobes, like humans, are stronger together than they ever could be alone.
Visit Us
750 Main Street
Cambridge, MA 02139
© 2025 Concerto Biosciences, Inc. All rights reserved.